Monthly Cost Breakdown: Wegovy vs Ozempic UK Pricing
Understanding the Difference Between Wegovy and Ozempic: Licensing and Legal Use
The primary difference between Wegovy and Ozempic lies in their MHRA licensing, which directly impacts legal prescribing and monthly costs. Wegovy is specifically licensed for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities, making it the only legal semaglutide option for weight loss in the UK. Ozempic, whilst containing the same active ingredient, is exclusively licensed for type 2 diabetes treatment, and promoting it for weight loss constitutes illegal off-label advertising.
This licensing difference between Wegovy and Ozempic creates distinct cost structures and supply chains. Wegovy follows a structured 16-week dose escalation protocol specifically designed for weight management, starting at 0.25mg and progressing to 2.4mg maintenance dose. The prescription-only medicine requires clinical assessment focusing on weight management criteria, unlike Ozempic's diabetes-focused prescribing requirements. EverydayMeds, registered with GPhC #9012878, ensures legal Wegovy supply through proper weight management clinical pathways.
Wegovy Monthly Cost Structure: Complete UK Pricing Breakdown
The difference between Wegovy and Ozempic monthly costs reflects their distinct therapeutic applications and dosing schedules. Wegovy's monthly costs follow the mandatory dose escalation: £79.99 for 0.25mg starter dose (weeks 1-4), £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to secure these final prices.
Bundle options provide supply convenience rather than savings, with the Intro Duo (0.25mg & 0.5mg) at £169.99 covering your first two months, and the Ultimate Stability Trio offering three months of 2.4mg maintenance supply for £649.99. The difference between Wegovy and Ozempic pricing reflects Wegovy's specialised weight management formulation and legal prescribing pathway. Annual maintenance cost at 2.4mg totals approximately £2,520, representing clear monthly budgeting for long-term weight management commitment.
Clinical Evidence: Difference Between Wegovy and Ozempic Trial Data
Clinical evidence demonstrates the difference between Wegovy and Ozempic through distinct trial programmes targeting different patient populations. The STEP trial programme specifically evaluated Wegovy for weight management, with STEP 1 showing patients achieving approximately 15% average weight loss at 68 weeks alongside diet and exercise, compared to 2.4% with placebo. STEP 2 focused on patients with type 2 diabetes, achieving around clinically studied weight loss, whilst STEP 3 combined Wegovy with intensive behavioural therapy for approximately clinically studied weight loss.
The SELECT cardiovascular outcomes trial revealed Wegovy's 20% reduction in major cardiovascular events (hazard ratio 0.80), demonstrating benefits beyond weight management as referenced in Wilding et al., NEJM, 2021. These trials specifically examined Wegovy's weight management indication, contrasting with Ozempic's diabetes-focused clinical programme. The difference between Wegovy and Ozempic trial populations reflects their distinct therapeutic targets and licensing applications.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone GLP-1 that regulates appetite and satiety. The medication works primarily on brain appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals. This mechanism may help reduce food cravings and support portion control when combined with a reduced-calorie diet and increased physical activity. The once-weekly injection maintains consistent GLP-1 receptor activation, providing sustained appetite regulation throughout the seven-day dosing interval. Clinical studies suggest this mechanism supports gradual, sustainable weight loss when patients adhere to the prescribed lifestyle modifications alongside Wegovy treatment.
EverydayMeds Ordering Process: Simple Clinical Assessment to Delivery
Accessing Wegovy through EverydayMeds involves a streamlined three-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within three working days (or 24 hours with express service), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, Wegovy ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The process includes comprehensive patient information leaflets and injection technique guidance, supporting confident self-administration. Our GPhC #9012878 registration ensures full regulatory compliance throughout the prescribing and dispensing process.
Storage and Practical Considerations: Wegovy Convenience Features
Wegovy storage requirements include refrigeration at 2-8°C before first use, with a significant practical advantage of remaining stable for up to six weeks at room temperature below 30°C once removed from the fridge. This flexibility supports travel and daily life convenience compared to medications requiring constant refrigeration. The FlexTouch pen design enables simple once-weekly subcutaneous injection into the abdomen, thigh, or upper arm, with pre-filled doses eliminating measurement requirements. Dose escalation follows a mandatory schedule over 16 weeks, allowing gradual tolerance development and side effect minimisation. The pen's user-friendly design includes clear dose indicators and automatic needle safety features for confident home administration.
Monthly Budget Planning: Long-term Wegovy Cost Management Strategy
Planning for the difference between Wegovy and Ozempic monthly costs requires understanding Wegovy's 16-week escalation period followed by ongoing maintenance expenses. The first four months total £414.96 (including escalation doses), whilst maintenance at 2.4mg costs £209.99 monthly thereafter. Returning customers benefit from DOSE25 discount code, ensuring consistent pricing throughout treatment duration. Annual budgeting should account for approximately £2,940 including the initial escalation period, then £2,520 annually at maintenance dose.
The difference between Wegovy and Ozempic cost structures reflects their distinct clinical applications and legal prescribing requirements. EverydayMeds' transparent pricing eliminates hidden fees or surprise charges, with all costs clearly displayed before checkout. Bundle options like the Consistency 2.4mg (×2) at £419.99 provide two-month supply security for established patients, supporting treatment continuity without monthly reordering.
Making Your Decision: Expert Clinical Support Available
The difference between Wegovy and Ozempic extends beyond monthly costs to encompass legal prescribing, clinical monitoring, and therapeutic outcomes. EverydayMeds provides both medications where clinically appropriate — Wegovy for weight management and Ozempic for type 2 diabetes patients. Our qualified prescribers assess individual circumstances, medical history, and treatment goals to recommend the most suitable option. Starting your weight management journey with Wegovy from £79.99 monthly involves comprehensive clinical assessment ensuring safe, effective treatment initiation. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, using code FIRST40 for new customer pricing, with ongoing DOSE25 support for returning patients maintaining their weight management commitment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
